Abstract
Objective
The aim of the present study was to map out what kind of psychotropic drugs are prescribed for elderly residents in assisted-living homes and how they relate to age, sex, form of living, psychiatric diagnosis, care needs and mental health status, and to identify factors of importance for their use; and to study the indication for treatment and the evaluation of the effects of treatment.
Method
The study had a cross-sectional design and included one-third of all patients (n=175) living in old-age homes or in nursing homes in a municipality in southern Sweden. Data concerning medication was obtained from medical records and included all psychotropic drugs prescribed the day the study started and the previous month. Need of care was assessed using Katz index, and mental health status was assessed using the Organic Brain Syndrome scale.
Results
Of the study population, 128 (73%) used one or more psychoactive drug. Prescribed drugs were neuroleptics (16%), anxiolytics (32%), hypnotics, (45%), and anti-depressants (33%). A greater prescription of neuroleptics than anti-depressants was seen for those showing signs of depression, and caution with prescription of benzodiazepines was seen for those showing signs of dementia. An indication and evaluation of treatment was lacking in half of the cases. Treatment with psychiatric drugs existed for approximately 50% of those without a determined psychiatric diagnosis.
Conclusion
We have found a frequent use of neuroleptics, anxiolytics and hypnotics in the elderly, but an underprescription of anti-depressants appears to exist. There is a lack of documentation of indications and evaluations of psychotropic medication.
Similar content being viewed by others
References
SCB (2001) Sweden's official statistics, statistical announcements BE 12 SM 0101. Population of the whole country, the counties and the municipalities 31 December 2000 (in Swedish). Statistiska Centralbyrån, Stockholm
Fastbom J, Claesson CB, Cornelius C, Thorslund M, Winblad B (1995) The use of medicines with anticholinergic effects in older people. J Am Geriatr Soc 43:1135–1140
Burns A (1997) Psychiatric symptoms and behavioural disturbances in the dementias. J Neural Transm 51:27–35
Elmståhl S, Stenberg I, Annerstedt, L, Ingvad B (1998) Behavioural disturbances and pharmacological treatment of patients with dementia in family care giving: a 2-year follow up. Int Psychogeriatr 10:239–252
Thacker S, Jones R (1997) Neuroleptic prescribing to the community elderly in Nottingham. Int J Geriatr Psychiatry 12:833–837
Furniss L, Lloyd Craig SK, Burns A (1998) Review: medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433–439
Schmidt I, Claesson C, Westerholm B, Svarstad BL (1998) Resident characteristics and organizational factors influencing the quality of drug use in Sweden nursing homes. Soc Sci Med 47:961–971
Schjott J, Opedal K, Rutledal JE (1999) A survey of hypnotic use in geriatric institutions in Sogn og Fjordane, Norway. Aging Clin Exp Res 11:50–55
Williams BR, Nichol MB, Lowe B, Yoon PS, McCombs JS, Margolies J (1999) Medication use in residential care facilities for the elderly. Ann Pharmacother 33:149–155
Ruths S, Straand J, Nygaard HA (2001) Psychotropic drug use in nursing homes—diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57:523–528
Sörensen L, Foldspang A, Gulmann NC, Munk-Jörgensen P (2001) Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16:147–154
Katona C (2001) Psychotropics and drug interactions in the elderly patient. Int J Geriatr Psychiatry 16:86–90
Fastbom J (2001) Elderly and drugs. Liber, Stockholm
Beers MH (1997) Explicit criteria for determining inappropriate medication use by the elderly: an update. Arch Intern Med 157:1531–1536
Steffens DC, Krishnan KRR (1998) Metabolism, bioavailability and drug interactions. Clin Geriatr Med 14:17–31
Cooper JW (1996) Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc 44:194–197
Turnheim K (1998) Drug dosage in the elderly. Is it rational? Drugs Aging 13:357–379
Atkin PA, Veitch PC, Veitch EM, Ogle SJ (1999) The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 14:41–52
Meador KJ (1998) Cognitive side effects of medication. Neurol Clin 16:141–155
Moore AR, O'Keeffe ST (1999) Drug-induced cognitive impairment. Drugs Aging 15:15–28
Mustard CA, Mayer T (1997) Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol 145:738–745
Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875–882
Monane M, Glynn RJ, Avorn J (1996) The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther 59:83–92
Ersser S, Wiles A, Taylor H, Wade S, Walsh R, Bentey T (1999) The sleep of older people in hospital and nursing homes. J Clin Nurs 8:360–368
Opedal K, Schjott J, Eide E (1998) Use of hypnotics among patients in geriatric institutions. Int J Geriatr Psychiatry 13:846–851
Evans DL, Staab JP, Petitto JM, et al (1999) Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60:40–55
Henderson AS, Korten AE, Jorm AF, et al (1994) Are nursing homes depressing? Lancet 344:1091
Arthur A, Matthews R, Jagger C, Lindesay J (2002) Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 17:54–60
Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in the development of an index of ADL. Gerontologist 10:20–30
Katz S, Ford AB, Moskowits RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919
Brorsson B, Hulter Åsberg K (1984) Katz index of independence in ADL: reliability and validity in short-term care. Scand J Rehabil Med 16:125–132
Jensen E, Dehlin O, Gustafson G (1993) A comparison between three psychogeriatric rating scales. Int J Geriatr Psychiatry 8:215–229
WHO Collaborating Centre for Drugs Statistics and Methodology (2000) Anatomical therapeutic chemical (ATC) classification index. World Health Organisation, Oslo
The National Board of Health and Welfare (1997) International classification of diseases and related health problems, tenth revision (ICD-10). Stockholm
SPSS (1993) Base system users guide. SPSS, Inc., Chicago
The National Board of Health and Welfare (1998) Ädelparadoxen: sjukhemmen före och efter Ädelreformen (in Swedish). Stockholm
Isacsson G (2000) Suicide prevention—a medical breakthrough? Acta Psychiatr Scand 102:113–117
Lasser RA, Sunderland T (1998) Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 46:202–207
Brorson S, Scanlan JM, Doane K, Gray S (2002) Antidepressant prescribing in nursing homes: is there a place for tricyclics? Int J Geriatr Psychiatry 17:1140–1145
Roberts MS, King M, Stokes JA, et al (1998) Medication prescribing and administration in nursing homes. Age Ageing 27:385–392
Newman SC, Hassan AI (1999) Antidepressant use in the elderly population in Canada: results from a national survey. J Gerontol A Biol Sci Med Sci 54:527–530
Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips C (2000) Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 29:165–172
Lader M (1997) Hypnotics in the elderly. Int J Geriatr Psychopharmacol 1:10–14
Bachman DL (1992) Sleep disorders with aging: evaluation and treatment. Geriatrics 47:53–61
Kennedy MM, Mion LC (1996) Neuroleptic therapy: how much do nurses know? J Gerontol Nurs 22:7–13
Elon R, Pawlson LG (1992) The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc 40:958–963
Miller SW (1993) Cost savings and reduction of medication related problems as a result of consultant pharmacy. Clin Pharm 8:1265–1271
Kane R, Garrard J (1994) Changing physician prescribing practices: regulation vs education. JAMA 271:393–394
Avorn J, Soumerai SB, Everitt DE, et al (1992) A randomized trial of program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 327:168–173
Acknowledgements
The authors wish to thank all staff members and residents at the nursing homes and old-age homes for their collaboration. We are most grateful to Christin Tornvall for help with interviews and to Anders Håkansson, Ph.D., for revising the language. The study was supported by Capio Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holmquist, IB., Svensson, B. & Höglund, P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59, 669–676 (2003). https://doi.org/10.1007/s00228-003-0679-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0679-y